The Valley Desk

NCT03236844 · Interventional trial

Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants

Overall registry status Completed

Phase 1

Conditions Healthy Participants

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov